74
Efficacy and safety of exercise training in patients with chronic heart
failure: HF-ACTION randomized controlled trial. JAMA. - 2009.
301:1439-1450.
113. O’Leary D.H., Polak J.F., Kronmal R.A., Manolio T.A., Burke G.L.,
Wolfson S.K. Carotid-artery intima and media thickness as a risk
factor for myocardial infarction and stroke in older adults.
Cardiovascular Health Study Collaborative Research Group. N Engl J
Med. - 1999. 340:14-22.
114. Orth-Gomer K., Schneiderman N., Wang H.X., Walldin C., Blom M.,
Jernberg T. Stress reduction prolongs life in women with coronary
disease: the Stockholm Women’s Intervention Trial for Coronary Heart
Disease (SWITCHD). Circ Cardiovasc Qual Outcomes. - 2009. 2:25-32.
115. Patel A., MacMahon S., Chalmers J., Neal B., Billot L., et al. Intensive
blood glucose control and vascular outcomes in patients with type 2
diabetes. N Engl J Med. - 2008. 358:2560-2572.
116. Patel A., MacMahon S., Chalmers J., Neal B., Woodward M., Billot
L., et al. Effects of a fixed combination of perindopril and indapamide
on macrovascular and microvascular outcomes in patients with type 2
diabetes mellitus (the ADVANCE trial): a randomised controlled trial.
Lancet. - 2007. 370:829-840.
117. Pedersen TR, Faergeman O, Kastelein JJ, Olsson AG, et al. High-dose
atorvastatin vs usual-dose simvastatin for secondary prevention after
myocardialinfarction: the IDEAL study: a randomized controlled trial.
JAMA. - 2005. - 294:2437-2445.
118. Piepoli M.F., Corra U., Benzer W., Bjarnason-Wehrens B., Dendale P.,
et al. Secondary prevention through cardiac rehabilitation: from
knowledge to implementation. A position paper from the Cardiac
Rehabilitation Section of the European Association of Cardiovascular
Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil. - 2010.
17:1-17.
119. Piepoli MF, Davos C, Francis DP, Coats AJ. Exercise training meta-
analysis of trials in patients with chronic heart failure (ExTraMATCH).
BMJ. - 2004. - 328:189.
120. Poirier P., Alpert M.A., Fleisher L.A., Thompson P.D., Sugerman H.J.,
et al. Cardiovascular evaluation and management of severely obese
patients undergoing surgery: a science advisory from the American
HeartAssociation. Circulation. - 2009. 120:86-95.
121. Poirier P., Cornier M.A., Mazzone T., Stiles S., Cummings S., et al.
Bariatric surgery and cardiovascular risk factors: a scientific statement
Klinik protokol Az
ərbaycan Respublikas
ı S
əhiyy
ə Nazirliyinin
İctimai S
əhi
yy
ə v
ə
İslahatlar M
ərk
əzind
ə haz
ırlanm
ış
dı
r.
75
from the American Heart Association. Circulation. - 2011. 123:1683-
1701.
122. Poulter N.R., Wedel H., Dahlof B., Sever P.S., Beevers D.G., et al.
Role of blood pressure other variables in the differential
cardiovascular event rates noted in the Anglo-Scandinavian Cardiac
Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA).
Lancet. - 2005. 366:907-913.
123. Preis SR, Hwang SJ, Coady S, Pencina MJ, et al. Trends in all-cause
and cardiovascular disease mortality among women and men with and
without diabetes mellitus in the Framingham Heart Study, 1950 to
2005. Circulation. - 2009. - 119:1728-1735
124. Prescott E., Hippe M., Schnohr P., Hein H.O., Vestbo J. Smoking and
risk of myocardial infarction in women and men: longitudinal
population study. BMJ. - 1998. 316:1043-1047.
125. Prescott E., Scharling H., Osler M., Schnohr P.. Importance of light
smoking and inhalation habits on risk of myocardial infarction and all
cause mortality. A 22 year follow up of 12 149 men and women in The
Copenhagen City Heart Study. J Epidemiol Community Health. -
2002. 56:702-706.
126. Raupach T., Schafer K., Konstantinides S., Andreas S.. Secondhand
smoke as an acute threat for the cardiovascular system: a change in
paradigm. Eur Heart J. - 2006. 27:386-392.
127. Ray KK, Cannon CP, McCabe CH, Cairns R, et al. Early and late
benefits of high-dose atorvastatin in patients with acute coronary
syndromes: results from the PROVE IT-TIMI 22 trial. J Am Coll
Cardiol. - 2005. -46:1405-1410.
128. Rayner M., Allender S., Scarborough P. Cardiovascular disease in
Europe. Eur J Cardiovasc Prev Rehabil. - 2009. - 16 Suppl 2: S43-S47.
129. Rees K., Bennett P., West R., Davey S.G., Ebrahim S. Psychological
interventions for coronary heart disease. Cochrane Database Syst Rev.
- 2004. 2: CD002902.
130. Richardson C.R., Kriska A.M., Lantz P.M., Hayward R.A. Physical
activity and mortalityacross cardiovascular disease risk groups. Med
Sci Sports Exerc. - 2004. 36:1923-1929.
131. Rigotti N.A., Pipe A.L., Benowitz N.L., Arteaga C., Garza D., Tonstad
S. Efficacy and safety of varenicline for smoking cessation in patients
with cardiovascular disease: a randomized trial. Circulation. - 2010.
121:221-229.
Klinik protokol Az
ərbaycan Respublikas
ı S
əhiyy
ə Nazirliyinin
İctimai S
əhi
yy
ə v
ə
İslahatlar M
ərk
əzind
ə haz
ırlanm
ış
dı
r.
76
132. Roest A.M., Martens E.J., de Jonge P., Denollet J. Anxiety and risk of
incident coronary heart disease: a meta-analysis. J Am Coll Cardiol,
2010. - 56:38-46.
133. Roest A.M., Martens E.J., Denollet J., de Jonge P. Prognostic
association of anxiety post myocardial infarction with mortality and
new cardiac events: a meta-analysis. Psychosom Med. - 2010. 72:563-
569.
134. Rose G. Sick individuals and sick populations. Int J Epidemiol. - 1985.
14:32-38.
135. Rollman B.L., Belnap B.H., LeMenager M.S., Mazumdar S., Houck
P.R., et al. Telephone-delivered collaborative care for treating post-
CABG depression: a randomized controlled trial. JAMA, - 2009. -
302:2095-2103.
136. Romero-Corral A., Montori V.M., Somers V.K., Korinek J., Thomas
R.J., et al. Association of bodyweight with total mortality and with
cardiovascular events in coronary artery disease: a systematic review
of cohort studies. Lancet. - 2006. 368:666-678.
137. Rozanski A., Blumenthal J.A., Davidson K.W., Saab P.G., Kubzansky
L. The epidemiology, pathophysiology, and management of
psychosocial risk factors in cardiac practice: the emerging field of
behavioral cardiology. J Am Coll Cardiol. - 2005. 45:637-651.
138. Rubak S., Sandbaek A., Lauritzen T., Christensen B. Motivational
interviewing: a systematic review and meta-analysis. Br J Gen Pract. -
2005. 55:305-312.
139. Ruilope L.M., Salvetti A., Jamerson K., Hansson L., Warnold I., Wedel
H., Zanchetti A. Renal function and intensive lowering of blood
pressure in hypertensive participants of the hypertension optimal
treatment (HOT) study. J Am Soc Nephrol, - 2001. - 12:218-225.
140. Sacco RL, Diener HC, Yusuf S, Cotton D, et al. Aspirin and extended-
release ipyridamole versus clopidogrel for recurrent stroke. N Engl J
Med. - 2008. - 359:1238-1251.
141. Sacks F.M., Svetkey L.P., Vollmer W.M., Appel L.J., Bray G.A., et al.
Effects on blood pressure of reduced dietary sodium and the Dietary
Approaches to Stop Hypertension (DASH) diet. DASH–Sodium
Collaborative Research Group. N Engl J Med. - 2001. 344:3-10.
142. Sandhu S, Wiebe N, Fried LF, Tonelli M. Statins for improving renal
outcomes: a meta-analysis. J Am Soc Nephrol. - 2006. - 17:2006-2016.
143. Sarwar N, Danesh J, Eiriksdottir G, Sigurdsson G, et al. Triglycerides
and the risk of coronary heart disease: 10,158 incident cases among
Klinik protokol Az
ərbaycan Respublikas
ı S
əhiyy
ə Nazirliyinin
İctimai S
əhi
yy
ə v
ə
İslahatlar M
ərk
əzind
ə haz
ırlanm
ış
dı
r.
77
262,525 participants in 29 Western prospective studies. Circulation. -
2007. - 115:450-458.
144. Scheinowitz M., Harpaz D. Safety of cardiac rehabilitation in a
medically supervised, community-based program. Cardiology. - 2005.
103:113-117.
145. Schiffrin E.L., Lipman M.L., Mann J.F. Chronic kidney disease:
effects on the cardiovascular system. Circulation, - 2007. - 116:85-97.
146. Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P,et al. Effects of
atorvastatin on early recurrent ischemic events in acute coronary
syndromes: the MIRACL study: a randomized controlled trial. JAMA.
- 2001. - 285:1711-1718.
147. Sehestedt T., Jeppesen J., Hansen T.W., Wachtell K., Ibsen H., et al.
Risk prediction is improved by adding markers of subclinical organ
damage to SCORE. Eur Heart J. - 2010. 31:883-891.
148. Shepherd J., Barter P., Carmena R., Deedwania P., Fruchart J.C., et al.
Effect of lowering LDL cholesterol substantially below currently
recommended levels in patients with coronary heart disease and
diabetes: the Treating to New Targets (TNT) study. Diabetes Care. -
2006. 29:1220-1226.
149. SIGN (Scottish Intercollegiate Guidelines Network) [Electronic
resource]: Risk Estimation and the Prevention of Cardiovascular
Disease. A National Clinical Guideline. - 2007. Report No. 97.
Availabe at: http://www.sign.ac.uk/pdf/sign97.pdf (12.02.2014).
150. Smith GD, Shipley MJ, Marmot MG, Rose G. Plasma cholesterol
concentration, mortality. The Whitehall Study. JAMA. - 1992. -
267:70-76.
151. Steenland K. Risk assessment for heart disease and workplace ETS
exposure among nonsmokers. Environ Health Perspect. - 1999. 107 //
Suppl 6:859-863.
152. Stead L.F., Lancaster T. Group behaviour therapy programmes for
smoking cessation. Cochrane Database Syst Rev. - 2005. 2:CD001007.
153. Stringhini S., Sabia S., Shipley M., Brunner E., Nabi H., Kivimaki M.,
Singh-Manoux A. Association of socioeconomic position with health
behaviors and mortality. JAMA. - 2010. 303:1159-1166.
154. Talbot L.A., Morrell C.H., Fleg J.L., Metter E.J. Changes in leisure
time physical activity and risk of all-cause mortality in men and
women: the Baltimore Longitudinal Study of Aging. Prev Med. - 2007.
45:169-176.
155. Taylor R.S., Brown A., Ebrahim S., Jolliffe J., Noorani H., et al.
Exercise-based rehabilitation for patients with coronary heart disease:
Klinik protokol Az
ərbaycan Respublikas
ı S
əhiyy
ə Nazirliyinin
İctimai S
əhi
yy
ə v
ə
İslahatlar M
ərk
əzind
ə haz
ırlanm
ış
dı
r.
78
systematic review and meta-analysis of randomized controlled trials.
Am J Med. - 2004. 116:682-692.
156. Theorell T., Emdad R., Arnetz B., Weingarten A.M. Employee effects
of an educational program for managers at an insurance company.
Psychosom Med. - 2001. 63:724-733.
157. Thompson P.D., Franklin B.A., Balady G.J., Blair S.N., Corrado D., et
al. Exercise and acute cardiovascular events placing the risks into
perspective: a scientific statement from the AmericanHeart Association
Council on Nutrition, Physical Activity, and Metabolism and the
Council on Clinical Cardiology. Circulation. - 2007. 115:2358-2368.
158. Thun M.J., Myers D.G., Day-Lally C., Namboodin M.M., Calle E.E.,
et al. Age and the exposure-response relationships between cigarette
smoking and premature death in Cancer Prevention Study II. Changes
in Cigarette-Related Disease Risks and Their Implications for
Prevention and Control. Smoking and Tobacco Control Monograph
No. 8. Bethesda, MD: US Department of Health and Human Services,
Public Health Service, National Institutes of Health, National Cancer
Institute. - 1997. 383-413.
159. Tipton C.M. ACSM’s Advanced Exercise Physiology. Baltimore, MD:
Lippincott Williams & Wilkins. - 2006.
160. Turnbull F., Neal B., Algert C., Chalmers J., Chapman N., et al. Effects
of different blood pressure-lowering regimens on major cardiovascular
events in individuals with and without diabetes mellitus: results of
prospectively designed overviews of randomized trials. Arch Intern
Med. - 2005. 165:1410-1419.
161. UK Prospective Diabetes Study Group. Effect of intensive blood-
glucose control with metformin on complications in overweight
patients with type 2 diabetes (UKPDS 34). Lancet. - 1998. 352:854-865.
162. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-
glucose control with sulphonylureas or insulin compared with
conventional treatment and risk of complications in patients with type
2 diabetes (UKPDS 33). Lancet. - 1998. 352:837-853.
163. US Department of Health and Human Services [Electronic resource]:
Physical Activity Guidelines Advisory Committee Report. 2008. -
Availabe
at:
http://www.health.gov/PAguidelines/
Report/
pdf/CommitteeReport.pdf. 312 (12.02.2014). // Richardson CR, Kriska
AM, Lantz PM, Hayward RA. Physical activity and mortality across
cardiovascular disease risk groups. Med Sci Sports Exerc. - 2004.
36:1923-1929.
Klinik protokol Az
ərbaycan Respublikas
ı S
əhiyy
ə Nazirliyinin
İctimai S
əhi
yy
ə v
ə
İslahatlar M
ərk
əzind
ə haz
ırlanm
ış
dı
r.
79
164. US Department of Health and Human Services [Electronic resource].
2008 Physical Activity Guidelines for Americans. - 2008. Availabe at:
http://www.health.gov/paguidelines/pdf/ paguide.pdf (12.02.2014).
165. Vogt M.T., Cauley J.A., Newman A.B., Kuller L.H., Hulley S.B.
Decreased ankle/arm blood pressure index and mortality in elderly
women. JAMA 1993; 270:465–469.
166. Wamala S.P., Mittleman M.A., Schenck-Gustafsson K., Orth-Gomer
K. Potential explanations for the educational gradient in coronary heart
disease: a population-based case-control study of Swedish women. Am
J Public Health. - 1999. 89:315-321.
167. Wald D.S., Law M., Morris J.K., Bestwick J.P., Wald N.J.
Combination therapy versus monotherapy in reducing blood pressure:
meta-analysis on 11,000 participants from 42 trials. Am J Med. - 2009.
122:290-300.
168. Wallentin L., Becker R.C., Budaj A., Cannon C.P., Emanuelsson H., et
al. Ticagrelor versus clopidogrel in patients with acute coronary
syndromes. N Engl J Med. - 2009.361:1045-1057.
169. Warren T.Y., Barry V., Hooker S.P., Sui X., Church T.S., Blair SN.
Sedentary behaviors increase risk of cardiovascular disease mortality
in men. Med Sci Sports Exerc. - 2010. 42:879-885.
170. Wattigney W.A., Mensah G.A., Croft J.B. Increasing trends in
hospitalization for atrial fibrillation in the United States, 1985 through
1999: implications for primary prevention. Circulation. - 2003.
108:711-716.
171. Weickert M.O., Pfeiffer A.F. Metabolic effects of dietary fiber
consumption and prevention of diabetes. J Nutr. - 2008. 138:439-442.
172. Whitlock G., Lewington S., Sherliker P., Clarke R., Emberson J., et al.
Body-mass index and cause-specific mortalityin 900 000 adults:
collaborative analyses of 57 prospective studies. Lancet. - 2009.
373:1083-1096.
173. Whooley M.A., de Jonge P., Vittinghoff E., Otte C., Moos R., et al.
Depressive symptoms, health behaviors, and risk of cardiovascular
events in patients with coronary heart disease. JAMA. - 2008.
300:2379-2388.
174. WHO Study Group on Tobacco Product Regulation TobReg.
Waterpipe Tobacco Smoking: Health Effects, Research Needs and
Recommended Actions by Regulators. - 2005.
175. Williams P.T. Physical fitness and activity as separate heart disease
risk factors: a meta-analysis. Med Sci Sports Exerc. - 2001. 33:754-761.
Klinik protokol Az
ərbaycan Respublikas
ı S
əhiyy
ə Nazirliyinin
İctimai S
əhi
yy
ə v
ə
İslahatlar M
ərk
əzind
ə haz
ırlanm
ış
dı
r.
80
176. Williams R.R., Hunt S.C., Heiss G., Province M.A., Bensen J.T., et al.
Usefulness of cardiovascular family history data for population-based
preventive medicine and medical research (the Health Family Tree
Study and the NHLBI Family Heart Study). Am J Cardiol. - 2001.
87:129-135.
177. Wiviott S.D., Braunwald E., McCabe C.H., Montalescot G., Ruzyllo W., et
al. Prasugrel versus clopidogrel in patients with acute coronary
syndromes. N Engl J Med. - 2007. 357:2001-2015.
178. World Health Organization. Joint WHO/FAO Expert Consultation on
Diet, Nutrition and the Prevention of Chronic Diseases. - 2002. Report
No. 916.
179. World Health Organization. Obesity: Preventing and Managing the
Global Epidemic.Report of a WHO Consultation. World Health
Organization Technical Report Series, Report No 894. - 1998.
180. Zanchetti A., Hansson L., Dahlof B., Julius S., Menard J., et al. Benefit
and harm of low-dose aspirin in well-treated hypertensives at different
baseline cardiovascular risk. J Hypertens. - 2002. 20:2301-2307.
181. Zheng W., McLerran D.F., Rolland B., Zhang X., Inoue M., et al.
Association between body-mass index and risk of death in more than 1
million Asians.N Engl J Med. - 2011. 364:719-729.
Klinik protokol Az
ərbaycan Respublikas
ı S
əhiyy
ə Nazirliyinin
İctimai S
əhi
yy
ə v
ə
İslahatlar M
ərk
əzind
ə haz
ırlanm
ış
dı
r.
Dostları ilə paylaş: |